In vitro induction of memory-driven responses against Neisseria meningitidis by priming with Neisseria lactamica

Vaccine

Volumn 20, Issue 23-24, 2002, Pages 2957-2963

  Sanchez S ^a   Troncoso, G ^a   Criado, M T ^a   Ferreiros C ^a  

^a UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

Author keywords

Memory driven response; Neisseria lactamica; Neisseria meningitidis

Indexed keywords

MENINGOCOCCUS VACCINE; OUTER MEMBRANE PROTEIN; BACTERIAL ANTIGEN; BACTERIUM ANTIBODY;

ANIMAL EXPERIMENT; ARTICLE; BACTERIAL COLONIZATION; BACTERICIDAL ACTIVITY; CONTROLLED STUDY; CROSS REACTION; IMMUNITY; IMMUNOLOGICAL MEMORY; IN VITRO STUDY; MENINGOCOCCOSIS; MOUSE; NEISSERIA; NEISSERIA LACTAMICA; NEISSERIA MENINGITIDIS; NONHUMAN; PRIORITY JOURNAL; ANIMAL; BAGG ALBINO MOUSE; BLOOD; HUMAN; IMMUNOLOGY; INNATE IMMUNITY; SERUM BACTERICIDAL ACTIVITY; SPECIES DIFFERENCE;

ANIMAL; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BLOOD BACTERICIDAL ACTIVITY; CROSS REACTIONS; HUMAN; IMMUNITY, NATURAL; IMMUNOLOGIC MEMORY; IN VITRO; MENINGOCOCCAL INFECTIONS; MENINGOCOCCAL VACCINES; MICE; MICE, INBRED BALB C; NEISSERIA; NEISSERIA MENINGITIDIS; SPECIES SPECIFICITY; SUPPORT, NON-U.S. GOV'T; ANIMALS; HUMANS;

EID: 0037178308     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(02)00224-4     Document Type: Article

References (25)

1. Hereditary deficiency of the seventh component of complement and recurrent meningococcal infection: Investigations of Irish family using a novel screening assay for complement activity an C7 M/N allotyping
2. Complement deficiency states and meningococal disease
3. Complement deficiency states and infection: Epidemiology, pathogenesis and consequences of neisserial and other infections in an immune deficiency
4. Detection of antibodies to common antigens of pathogenic and commensal Neisseria species
5. Meningococcal disease
6. Human immunity to the meningococcus. Part II. Development of natural immunity
7. Epidemiology and prevention of meningococcal disease
8. Carriage of Neisseria meningitidis and Neisseria lactamica in infants and children
9. Development of natural immunity to Neisseria meningitidis
10. Meningococcal vaccines: Current status and future possibilities
11. Mathematical modelling of infection and disease due to Neisseria meningitidis and Neisseria lactamica
12. Analysis of the expresion of the putatively virulence-associated neisserial protein Rmp (class 4) in commensal Neisseria and Moraxella catarrhalis strains
13. Antigenic cross-reactivity between outer proteins of Neisseria meningitidis and commensal Neisseria species
14. Blocking of iron uptake from transferrin by antibodies against the transferin binding proteins in Neisseria meningitidis
15. Bactericidal activity of antibodies elicited against the Neisseria meningitidis 37 kDa ferric binding protein (FbpA) with different adjuvants
16. Measurement of protein using bicinchonic acid
17. Protection against infection with Neisseria meningitidis group B serotype 2b by passive immunization with serotype-specific monoclonal antibody
18. Complement-mediated bacterial killing assays
19. Complement mediated bactericidal activity of human antibodies to poly α2-8 N-acetylneuraminic acid, the capsular polysaccharide of Neisseria meningitidis serogroup B
20. Assessment of immune response to meningococcal disease: Comparison of a whole blood assay and the serum bactericidal assay
21. Solid-phase screening of monoclonal antibodies
22. Serum bactericidal activity in a secondary school population following an outbreak of meningococcal disease: Effects of carriage and secretor status
23. Vaccines for prevention of meningococcal disease
24. Development of a meningococcal vaccine
25. Evaluation of cross-reactive antigens as determinants of cross-bactericidal activity in pathogenic and commensal Neisseria